BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

EUSA Pharma 



New York City  New York    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Jazz Pharmaceuticals, plc (JAZZ) Completes EUSA Pharma Acquisition 6/12/2012 11:06:44 AM    More...
Jazz Pharmaceuticals, Inc. (JAZZ) Buying EUSA Pharma for Up to $700 Million 4/27/2012 7:34:48 AM    More...
Alize Pharma Licenses its ASPAREC(R) Therapy for Treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma 2/2/2012 10:59:33 AM    More...
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma 2/2/2012 9:56:44 AM    More...
AIBioTech Assists EUSA Pharma in Obtaining FDA Approval for a Critical Drug Product 11/22/2011 7:53:20 AM    More...
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia 11/18/2011 7:15:08 AM    More...
EUSA Pharma Submits ERWINASE(R) Biologics License Application (BLA) for Treatment of Acute Lymphoblastic Leukemia 11/9/2010 11:24:29 AM    More...
EUSA Pharma Announces the Appointment of Stephen A. Stamp to Its Board of Directors 9/1/2010 11:03:54 AM    More...
EUSA Pharma Grants Japanese Rights To Erwinase(R) Oncology Therapy To Ohara Pharmaceutical 7/6/2010 2:32:48 PM    More...
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region 3/8/2010 7:17:33 AM    More...
123

//-->